Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Buoyed By Big Offers And Repository of Data, Aurobindo Branches Out Into CRAMS Business With Aurosource

This article was originally published in PharmAsia News

Executive Summary

HYDERABAD, India - Athough a relatively late entrant into the contract research and manufacturing space in India, Aurobindo Pharma with its new logo "Nothing compromised" thinks there is still enough room to forge credible relationships with Western companies for newly floated CRAMS unit Aurosource
Advertisement

Related Content

With Oxygen Healthcare Buy, India's Piramal Healthcare Breathes More Life Into Its Chemistry Skills
With Oxygen Healthcare Buy, India's Piramal Healthcare Breathes More Life Into Its Chemistry Skills
Pfizer Deal To Help Propel Aurobindo's Revenues To $2 Billion In Three Years
Pfizer Deal To Help Propel Aurobindo's Revenues To $2 Billion In Three Years
Advertisement
UsernamePublicRestriction

Register

SC074468

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel